drugset / Trial / NCT02440841
Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of Fedovapagon
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the potential for co-administration of strong inhibitors or inducers of CYP3A4 to alter the pharmacokinetics of fedovapagon.
Timeline
- Start
- 2015-05
- Primary completion
- 2015-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fedovapagon | Unknown | — | — |
| Subject | Itraconazole | Small molecule | — | — |
| Subject | Rifampicin | Small molecule | — | — |
Indications
No indication recorded.